Ellis M E, Hussain M, Webb A K, Barker N P, Fitzsimons T J
Br J Clin Pharmacol. 1984;17 Suppl 1(Suppl 1):59S-64S. doi: 10.1111/j.1365-2125.1984.tb02429.x.
The effects of chronic cimetidine therapy on the pharmacodynamic properties of atenolol and metoprolol were assessed in eight asthmatic patients using a placebo-controlled trial. When atenolol and metoprolol were administered at doses which achieved an equivalent degree of beta1-adrenoceptor blockade, metoprolol caused a significantly greater reduction in mean forced expiratory volume in one second (FEV1). This demonstrates the greater cardioselectivity of atenolol. The reductions in mean FEV1 induced by either atenolol or metoprolol were each unaffected by cimetidine. Plasma levels of each of the beta-adrenoceptor blockers were not affected by the addition of cimetidine. The FEV1 in one patient was further reduced when cimetidine was administered with metoprolol, although there was no corresponding change in plasma levels of drug. In this patient there was no such further reduction in FEV1 with atenolol. This study has not provided evidence for a pharmacodynamic interaction between cimetidine and either atenolol or metoprolol, but further studies are indicated.
采用安慰剂对照试验,在8名哮喘患者中评估了西咪替丁长期治疗对阿替洛尔和美托洛尔药效学特性的影响。当阿替洛尔和美托洛尔以达到同等程度β1肾上腺素能受体阻滞的剂量给药时,美托洛尔导致一秒用力呼气量(FEV1)的平均降低幅度显著更大。这证明了阿替洛尔具有更高的心脏选择性。阿替洛尔或美托洛尔引起的FEV1平均降低幅度均不受西咪替丁影响。添加西咪替丁后,两种β肾上腺素能受体阻滞剂的血浆水平均未受影响。当西咪替丁与美托洛尔合用时,1名患者的FEV1进一步降低,尽管药物血浆水平没有相应变化。在该患者中,阿替洛尔并未使FEV1出现这种进一步降低的情况。本研究未提供西咪替丁与阿替洛尔或美托洛尔之间存在药效学相互作用的证据,但仍需进一步研究。